** GenScript Biotech jumps as much as 7.2% to HK$10.98, highest since Dec. 11, 2024
** Stock set for biggest one-day pct rise since Oct. 22, 2024 and is on course for sixth consecutive session of gains
** Co's associate Legend Biotech announces its drug CARVYKTI, used to treat cancer of the bone marrow, brought in ~$334 mln in net trade sales in quarter ended Dec. 31, 2024, up from year-ago $159 mln
** GenScript fell 50.5% last year
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。